Leaders in Respiratory and Critical Care Medicine
Wake Forest Baptist Medical Center is ranked among the nation's best pulmonary and respiratory disorders hospitals by U.S. News & World Report (#21 in 2012-2013).
A leader in critical care and airways diseases research and clinical practice, the core of our expertise lies in extensive clinical knowledge gained through active research in asthma and chronic obstructive pulmonary disease, acute lung injury, lung cancer, critical care, and evaluation and treatment of obstructive airway disease.
Wake Forest Baptist's Pulmonary, Critical Care, Allergy and Immunologic Diseases Section received several prominent grants this year including:
- National Heart, Lung, and Blood Institute (NHLBI) funded multicenter Severe Asthma Research Program (SARP), which includes renewed funding through 2018.
- National Institute of Allergy and Infectious Diseases (NIAID) funding for a multicenter network focused on antimicrobial resistance in healthcare associated pneumonia.
- National Institute on Aging (NIA) support for a multicenter network to establish the impact of antipsychotics in ICU associated delirium.
- Support from the Department of Defense (DOD) to study the impact of early ICU rehabilitation in burn patients.
- The Parker B. Francis Foundation, which will support further studies on skeletal muscle wasting in acute lung injury (ALI).
- The Mesothelioma Applied Research Foundation (MARF), which will explore the genomics of patients with mesothelioma.
The year has also included multiple new funding applications including:
- Application to join the NHLBI funded PETAL Network, which represents the renewal of the ARDS Network with an enhanced focus on prevention and early treatment of patients with ALI.
- NHLBI funding to continue translational studies focused on mechanisms for surfactant injury in ALI.
- Applications to NIA to explore the impact of aging on recovery of muscle wasting in ALI.
- NHLBI applications to further explore the impact of rare genetic variants in beta agonist receptors on asthma severity and outcomes.
Multicenter Clinical Networks
Wake Forest Baptist serves as a primary study site for several National Heart, Lung, and Blood Institute multicenter clinical networks:
We are also involved in the evaluation and treatment of sleep disorders, the treatment of occupational pulmonary disease such as mesothelioma and asbestosis, and the active investigation of genetic susceptibility in respiratory diseases conducted through the Center of Genomics and Personalized Medicine.